|
Market Closed -
NYSE
16:00:02 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 47.03 USD | -0.32% |
|
-4.49% | -4.10% |
| 10-02 | Major drugmakers turn to China for licensing deals | RE |
| 10-01 | GSK plc : JP Morgan reiterates its Sell rating | ZD |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GSK PLC | Other Pharmaceuticals | -0.32% | -4.49% | -4.10% | +8.49% | -1.33% | 94.34B |
-
|
-
|
-
|
- Stock Market
- Stocks
- GSK Stock
- GSK Stock
- Charts GSK plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
